Friday Mar 29, 2024
Friday Mar 29, 2024

Pfizer asks Japan to approve COVID-19 vaccine for children


Nepalnews
2021 Nov 10, 17:39, Washington
In this Friday, January 22, 2021, file photo, empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination centre at the University of Nevada, Las Vegas. (Photo via AP)

 Pharmaceutical companies Pfizer and BioNTech have filed an application with the Japanese Ministry of Health, Labour and Welfare for approval of their COVID-19 vaccine for children aged five to 11, according to a statement released on Wednesday.

Along with the application, the companies submitted data on the second of the three phases of clinical trials conducted in foreign countries.

If approved, the Pfizer/BioNTech vaccine will become the first COVID-19 vaccine administered to children under 11 in Japan. Currently, Pfizer's vaccine is available exclusively to those aged 12 and above.

Apart from the Pfizer/BioNTech medicine, Japan also uses Moderna or AstraZeneca vaccines in its COVID-19 immunization campaign.

To date, the country has administered over 193 million doses of COVID-19 vaccines, which means about 74 per cent of the population has been fully vaccinated. Over 77 per cent of the population has received at least one dose of vaccine.

READ ALSO:

Pfizer BioNTech pharmaceutical companies COVID-19 vaccine children Japan Moderna AstraZeneca vaccines
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal